
Autopoiesis Sciences builds AI models that help researchers generate and validate scientific discoveries across complex domains. The company develops foundational reasoning capabilities and advanced AI architectures to enable autonomous discovery where traditional methods struggle. It provides a B2B AI platform and model-based tools for research teams, integrating with research workflows and data analysis pipelines. Core technologies include next-generation reasoning models, inference engines, and scalable model deployment for technical users.

Autopoiesis Sciences builds AI models that help researchers generate and validate scientific discoveries across complex domains. The company develops foundational reasoning capabilities and advanced AI architectures to enable autonomous discovery where traditional methods struggle. It provides a B2B AI platform and model-based tools for research teams, integrating with research workflows and data analysis pipelines. Core technologies include next-generation reasoning models, inference engines, and scalable model deployment for technical users.
What they do: Build AI models and platform for scientific discovery in life sciences and biotech
Stage & HQ: Early-stage (Seed); San Francisco, CA
Founders: Joseph Reth; Eike Gerhardt; Larry Callahan
Funding: Seed round with multiple investors (seed close: 2025-07-30)
Scientific discovery and research acceleration for life sciences, chemistry, and medical research.
2025
Biotechnology
Seed round with multiple individual and institutional investors (investors listed across profiles include Adam Grosser, Ally Warson, Alpaca VC, Cross Atlantic Angels, Hiro Mizushima, Informed Ventures, Mike Mahlkow, Tomas Urena Munoz, Vanessa Cann)
“Multiple angel and early-stage investors including individual angels and small VCs”
| Company |
|---|